Arsenal Capital Partners Analysis
What is Arsenal Capital Partners?
Private equity firm with $10B+ raised, 25 years in industrials and healthcare
Product Features & Capabilities
- Investments in middle-market industrial and healthcare companies
- Platform and add-on transactions
- Strategic growth strategies with value-add solutions
- Management team partnerships
- Portfolio acquisitions and divestitures
Investment Focus
Arsenal Capital Partners is a specialized private equity firm that primarily focuses on the healthcare and industrial sectors. Their investment strategy emphasizes building high-growth companies through technology and innovation-rich approaches. Arsenal typically engages in late-stage investments, partnering with management teams and business owners to develop tailored strategies that enhance value in their target markets. The firm has a strong track record, having completed over 300 platform and add-on transactions and raised more than $10 billion in institutional funds.
Assets Under Management
$10 billion
Investment Geography
Arsenal Capital Partners primarily invests in the United States, focusing on the lower middle market in the healthcare and industrial sectors.
Key Portfolio Companies
- 3DR Labs - Technology-enabled outsourced imaging solutions for radiology departments.
- Accella - Formulated polyurethane products and solutions.
- Airnov - Active packaging solutions for pharmaceuticals, diagnostics, and nutraceutical products.
- Applied Adhesives - Value-added distributor of adhesives.
- ATP Adhesive Systems - Water-based adhesive tapes.
- AvCarb - Advanced materials serving renewable energy technology.
- BioIVT - Biospecimens and other products for drug discovery and development.
- CellCarta - Immune therapy and biologic drug development services.
- Certara - Biosimulation software and technology to transform drug discovery and development.
- Charter Brokerage - Third-party logistics services to petroleum, chemical, and airline industries.
- Chroma Color - Color concentrates and additives for plastics.
- DG3 - Graphic, printing, and business services.
- Epic Sciences - Liquid biopsy diagnostics solutions company.
- Hopebridge - Autism therapy services.
- OncoHealth - Digital health solutions for oncology.
- Scientific Protein Laboratories - Active pharmaceutical ingredients.
- WCG Clinical Services - Pharmaceutical clinical trial optimization solutions.
Notable Exits
- Certara - Arsenal announced the sale of Certara, a leading provider of technology-enabled drug development solutions, while retaining a significant minority investment stake.
- TractManager - Another notable exit was TractManager, a company that provides healthcare contract management solutions. The details of the exit method were not specified, but it reflects Arsenal's focus on healthcare technology.
- Seal For Life Industries - Arsenal exited this company through an acquisition, which was completed on February 15, 2024.
- Airnov
Recent Fundraising
Management Team
The management team of Arsenal Capital Partners includes the following key members:
- **Joelle Marquis** - President
- **Frank Scrudato** - Chief Financial Officer and Chief Compliance Officer
- **George Abd** - Operating Partner
- **Dimitris Agrafiotis** - Director, Digital, Analytics, & AI
- **Sameen Ahmed** - Administrative Assistant
- **Irina Avrorina** - Position not specified
